Atlanta Capital Management’s Novartis NVS Stock Holding History

Atlanta Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-270,817	Closed	-$17.7M	–	158
2016 Q4	$17.7M	Sell	270,817 -25,762	-9%	-$1.67M	0.11%	138
2016 Q3	$21M	Sell	296,579 -27,586	-9%	-$2.01M	0.14%	134
2016 Q2	$24M	Sell	324,165 -206,204	-39%	-$14.2M	0.16%	123
2016 Q1	$34.4M	Sell	530,369 -17,697	-3%	-$1.2M	0.25%	99
2015 Q4	$42.3M	Sell	548,066 -90,232	-14%	-$7.17M	0.31%	87
2015 Q3	$52.6M	Sell	638,298 -12,141	-2%	-$1.08M	0.39%	86
2015 Q2	$57.3M	Buy	650,439 +357,620	+122%	+$32.8M	0.39%	86
2015 Q1	$25.9M	Sell	292,819 -1,898	-0.6%	-$168K	0.18%	133
2014 Q4	$24.5M	Sell	294,717 -14,933	-5%	-$1.24M	0.17%	131
2014 Q3	$26.1M	Sell	309,650 -5,943	-2%	-$481K	0.19%	123
2014 Q2	$25.6M	Sell	315,593 -2,335	-0.7%	-$184K	0.17%	125
2014 Q1	$24.2M	Sell	317,928 -107,274	-25%	-$7.82M	0.17%	136
2013 Q4	$30.6M	Sell	425,202 -15,466	-4%	-$1.08M	0.2%	125
2013 Q3	$30.3M	Sell	440,668 -2,112	-0.5%	-$140K	0.21%	121
2013 Q2	$28.1M	Buy	+442,780	New	+$28.8M	0.21%	116

Other funds holding NVS

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $22.8B AUM 25.09% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Atlanta Capital Management's NVS Position: Q1 2017 in Review

Atlanta Capital Management sold out of Novartis (NVS) in Q1 2017, closing a stake of 270,817 shares — an estimated $17.7M sold.

Atlanta Capital Management first reported a position in NVS in Q2 2013 and held it in 15 quarters. The position peaked at $57.3M in Q2 2015. 910 funds tracked by Wall St. Rank hold NVS as of Q1 2017.

Atlanta Capital Management reported no remaining Novartis position as of Q1 2017 after selling out during the quarter.
Atlanta Capital Management sold 270,817 Novartis shares in Q1 2017, an estimated $17.7M.
Atlanta Capital Management first reported a position in Novartis in Q2 2013 and held it in 15 quarters.
Atlanta Capital Management's Novartis position peaked at $57.3M in Q2 2015.
910 funds tracked by Wall St. Rank held Novartis as of Q1 2017.

Based on Atlanta Capital Management's 13F filing for Q1 2017, filed 15 May 2017.